Global
health concerns regarding the Zika virus, a flavivirus, have prompted the U.S. FDA
to issue guidance for blood donation collection, recommending that donors at
risk for the virus defer donations for four weeks. The FDA also noted in its
guidance that it is unlikely for the virus to be transmitted through
fractionated plasma-derived products, such as intravenous immunoglobulin (IVIG)
or von Willebrand factor (VWF) and coagulation factor VIII (FVIII) because of
existing viral inactivation and removal methods.
Posted by Dr. Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources